Trials / Recruiting
RecruitingNCT06323473
Maitake for Integrative Cancer Care
Maitake for Integrative Cancer Care: An Open Label, Uncontrolled Trial in People on Systemic Cancer Therapy
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- The Canadian College of Naturopathic Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Maitake is an edible mushroom that is used for both its nutritional and medicinal properties. Human and animal studies have shown Maitake may help improve immune function; however, its effectiveness in people with cancer is not clear. The investigators aim to measure if Maitake has any immunomodulatory effects when given alongside conventional systemic cancer therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Black Maitake Prothera | Mushroom extract; liquid |
Timeline
- Start date
- 2024-10-15
- Primary completion
- 2026-05-15
- Completion
- 2026-05-15
- First posted
- 2024-03-21
- Last updated
- 2026-01-23
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT06323473. Inclusion in this directory is not an endorsement.